Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation
Authors:
- Jacek KwiecinskiJKJacek Kwiecinski
- Evangelos TzolosETEvangelos Tzolos
- Timothy R.G. CartlidgeTCTimothy R.G. Cartlidge
- Alexander FletcherAFAlexander Fletcher
- Mhairi K. DorisMDMhairi K. Doris
- Rong BingRBRong Bing
- Jason M. TarkinJTJason M. Tarkin
- Michael A. SeidmanMSMichael A. Seidman
- Gaurav S. GulsinGGGaurav S. Gulsin
- Nicholas L. CrudenNCNicholas L. Cruden
- Anna K. BartonABAnna K. Barton
- Neal G. UrenNUNeal G. Uren
Open Access
- 26 October 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (17) , 1396-1408
Abstract
Background: Major uncertainties remain regarding disease activity within the retained native aortic valve, and regarding bioprosthetic valve durability, after transcatheter aortic valve implantation (TAVI). We aimed to assess native aortic valve disease activity and bioprosthetic valve durability in patients with TAVI in comparison with subjects with bioprosthetic surgical aortic valve replacement (SAVR). Methods: In a multicenter cross-sectional observational cohort study, patients with TAVI or bioprosthetic SAVR underwent baseline echocardiography, computed tomography angiography, and 18 F-sodium fluoride ( 18 F-NaF) positron emission tomography. Participants (n=47) were imaged once with 18 F-NaF positron emission tomography/computed tomography either at 1 month (n=9, 19%), 2 years (n=22, 47%), or 5 years (16, 34%) after valve implantation. Patients subsequently underwent serial echocardiography to assess for changes in valve hemodynamic performance (change in peak aortic velocity) and evidence of structural valve dysfunction. Comparisons were made with matched patients with bioprosthetic SAVR (n=51) who had undergone the same imaging protocol. Results: In patients with TAVI, native aortic valves demonstrated 18 F-NaF uptake around the outside of the bioprostheses that showed a modest correlation with the time from TAVI ( r =0.36, P =0.023). 18 F-NaF uptake in the bioprosthetic leaflets was comparable between the SAVR and TAVI groups (target-to-background ratio, 1.3 [1.2–1.7] versus 1.3 [1.2–1.5], respectively; P =0.27). The frequencies of imaging evidence of bioprosthetic valve degeneration at baseline were similar on echocardiography (6% versus 8%, respectively; P =0.78), computed tomography (15% versus 14%, respectively; P =0.87), and positron emission tomography (15% versus 29%, respectively; P =0.09). Baseline 18 F-NaF uptake was associated with a subsequent change in peak aortic velocity for both TAVI ( r =0.7, P r =0.7, P 18 F-NaF uptake was the only predictor of peak velocity progression ( P <0.001). Conclusions: In patients with TAVI, native aortic valves demonstrate evidence of ongoing active disease. Across imaging modalities, TAVI degeneration is of similar magnitude to bioprosthetic SAVR, suggesting comparable midterm durability. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02304276.Keywords
This publication has 30 references indexed in Scilit:
- Optimization and Reproducibility of Aortic Valve 18F-Fluoride Positron Emission Tomography in Patients With Aortic StenosisCirculation: Cardiovascular Imaging, 2016
- Demons versus level-set motion registration for coronary 18F-sodium fluoride PETProceedings of SPIE, 2016
- Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantationEuropean Heart Journal - Cardiovascular Imaging, 2016
- Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic PlaquesJournal of Nuclear Medicine, 2015
- 18F-Sodium Fluoride Uptake Is a Marker of Active Calcification and Disease Progression in Patients With Aortic StenosisCirculation: Cardiovascular Imaging, 2014
- The living aortic valve: From molecules to functionGlobal Cardiology Science and Practice, 2014
- Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic StenosisCirculation, 2012
- Calcific Aortic Valve Disease: Not Simply a Degenerative ProcessCirculation, 2011
- Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler UltrasoundJournal of the American Society of Echocardiography, 2009
- Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic StenosisCirculation, 2002